Samsara BioCapital GP, LLC - May 30, 2024 Form 4 Insider Report for CARGO Therapeutics, Inc. (CRGX)

Role: 10%+ Owner
Signature: Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member
Stock symbol: CRGX
Transactions as of: May 30, 2024
Transactions value $: $4,998,000
Form type: 4
Date filed: 6/3/2024, 09:45 PM
Previous filing: Dec 6, 2024
Next filing: Nov 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRGX	Common Stock	Purchase	$5M	+294K	+7.13%	$17.00	4.42M	May 30, 2024	By Samsara BioCapital, L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Samsara BioCapital GP, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.

Content

Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.